You are here

Article Text

Article menu
Download PDFPDF
Editorial
To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation

https://doi.org/10.1136/heartjnl-2016-310255

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests GYHL has served as a consultant for Bayer/Janssen, BMS/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife and Daiichi-Sankyo. Speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche and Daiichi-Sankyo.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles